Xtant Medical Holdings Inc. Overview

Xtant Medical Holdings, Inc., a company operating within the health care equipment and supplies sector, is recognized as a holding company. The company focuses on developing, acquiring, manufacturing, and commercializing regenerative surgical products aimed at treating degenerative, traumatic, and deformity conditions. Serving primarily the United States market, Xtant Medical Holdings leverages its subsidiaries to advance its product offerings.

Financial Snapshot

As of May 4, 2025, Xtant Medical Holdings Inc. reported a close price of $0.50 per share on the NYSE American exchange. The company’s stock has experienced fluctuations over the past year, with a 52-week high of $0.84 on May 13, 2024, and a 52-week low of $0.33 on December 15, 2024. The market capitalization stands at $65,340,000 USD, reflecting its current valuation in the market.

Earnings and Valuation

The company’s price-to-earnings (P/E) ratio is currently at -3.8, indicating that it is not generating positive earnings at this time. This metric is crucial for investors assessing the company’s profitability and future growth potential.

Industry and Operations

Xtant Medical Holdings operates in the health care equipment and supplies industry, focusing on regenerative surgical products. These products are designed to address a range of medical conditions, including degenerative, traumatic, and deformity-related issues. The company’s strategic approach involves leveraging its subsidiaries to enhance its product development and commercialization efforts.

Market Presence

Xtant Medical Holdings is listed on the NYSE American exchange, providing it with a platform to engage with investors and stakeholders. For more detailed information about its products and services, interested parties can visit the company’s website at www.xtantmedical.com .

In summary, Xtant Medical Holdings Inc. continues to navigate the health care equipment and supplies sector with a focus on regenerative surgical products. Despite current financial challenges, as indicated by its negative P/E ratio, the company remains committed to serving its customer base in the United States.